Prof Richard Scolyer named Outstanding Cancer Researcher of the Year  

Prof Richard Scolyer named Outstanding Cancer Researcher of the Year  

27 November 2020

The ground-breaking work of MIA's Co-Medical Director Professor Richard Scolyer, one of the world’s leading cancer pathologists, has today been recognised with NSW’s highest accolade for cancer research at the 2020 NSW Premier’s Awards for Outstanding Cancer Research.  

The Outstanding Cancer Researcher of the Year Award is awarded to an individual researcher who has made an active, outstanding, sustained contribution to any field of cancer research in NSW; has a record of substantive and noteworthy publications; and has supported, developed and mentored cancer researchers.

Professor Scolyer was named Outstanding Cancer Researcher of the Year at this year’s awards, which were hosted online due to the impact of COVID-19, for his pioneering melanoma research which has made a worldwide difference to the assessment, management and survival of people with cancer.   

Chief Cancer Officer and CEO of the Cancer Institute NSW, Professor David Currow, said the body of work amassed by Professor Scolyer throughout his career has made a real difference to how clinicians and researchers think about melanoma.  

“Over the past 20 years, Professor Scolyer has made an extraordinary and significant contribution to the field of cancer medicine through pathology. He is the most published scientist in the world in the field of melanoma pathology, he leads a world-renowned translational research laboratory at the University of Sydney, and he is the co-lead of the world’s largest melanoma treatment facility, the Melanoma Institute of Australia,” Professor Currow said.   

“Sadly, melanoma is Australia’s national cancer, with a person diagnosed in NSW, on average, every six hours. This year, around 16,000 Australians will be diagnosed and around 1400 are expected to die from the disease.  

“Ten years ago, people diagnosed with advanced melanoma had their life expectancy measured in months. Now, Australian people with melanoma have a range of increasingly personalised treatment options. There are people alive today, in NSW and around the world, thanks to work done by Professor Scolyer and his amazing teams,” he said. 

Premier Gladys Berejiklian congratulated Professor Scolyer on his remarkable career. 

“I want to thank and congratulate Professor Scolyer for his ground-breaking research into melanoma, a cancer that affects the lives of so many Australians,” Ms Berejiklian said. 

Commenting on his award win, Prof Scolyer said,

“We have an amazing team of people doing world leading melanoma research and it’s a huge honour to be leading that team and to be recognised in this way. Pathologists have a unique role to play in translational research and are key members of multidisciplinary teams which are conducting research at a high level. Pathologists are the bridge between the patient and what goes on in the research laboratory, bringing a unique perspective in order to facilitate research.”

For two decades, Prof Scolyer has been at the forefront of virtually all major advances in melanoma which have revolutionised management worldwide and resulted in vast improvements in survival of melanoma patients.

“Every cancer patient ultimately has their cancer diagnosed by a pathologist; what we see down the microscope and include in our reports determines how a patient is managed. The thing about research is that there is an opportunity not only to benefit a single patient, but to make a difference to many thousands of patients that will be affected down the track. This is what makes research so important,” said Prof Scolyer.

The NSW Government, through the Cancer Institute NSW, has invested more than $240 million in cancer research since 2011. 

For a full list of winners of the 2020 NSW Premier’s Awards for Outstanding Cancer Research, visit: Cancer Premiers Research Awards 

Prestigious award in pathology for Professor Scolyer
09 Feb 2018

Prestigious award in pathology for Professor Scolyer

Congratulations to Professor Richard Scolyer who was awarded the William O. Russell/Joanne Vandenberge Hill Award of Excellence in Pathology.

A Day in the Life Of... Serigne Lo
09 Feb 2018

A Day in the Life Of... Serigne Lo

A Day in the Life Of... Serigne Lo, Research and BioStatistics Manager at Melanoma Institute Australia

Jay inspires others to help end melanoma and so can you
07 Feb 2018

Jay inspires others to help end melanoma and so can you

Jay was your typical Aussie bloke – a truck driver, husband, dad and mate to many. Then he got melanoma. His cancer diagnosis turned his life upside down.

A dilemma no mother-to-be should face
31 Jan 2018

A dilemma no mother-to-be should face

Clair faced an impossible choice – risk delivering her baby early, or delay potentially life-saving melanoma treatment

Join little Madi and Bettina in the fight against melanoma
25 Jan 2018

Join little Madi and Bettina in the fight against melanoma

Little Madi misses her Dad. But she is determined to honour his memory and support life-saving melanoma research.

Toyota and country music fans invited to tip their hat to help tackle Australia's national cancer – melanoma
19 Jan 2018

Toyota and country music fans invited to tip their hat to help tackle Australia's national cancer – melanoma

Melanoma Institute Australia has teamed up with the Toyota Country Music Festival 2018 in Tamworth!

Sun Protection: Facts and Controversies
18 Jan 2018

Sun Protection: Facts and Controversies

MIA's dermatologist shares her knowledge with GPs on debunking myths and controversies on sunscreen.

Shannan Ponton joins our March for a cure
17 Jan 2018

Shannan Ponton joins our March for a cure

Shannan Ponton thought he was invincible – he wasn’t. But his melanoma battle ended up saving more than his own life. 

Surprising finding in rare form of melanoma get patients closer to personalised medicine
11 Jan 2018

Surprising finding in rare form of melanoma get patients closer to personalised medicine

Researchers have demonstrated that immunotherapy is highly effective in treating a rare form of melanoma – a result that is surprising due to the nature of the tumour.  

Using new technology to prevent melanoma
14 Dec 2017

Using new technology to prevent melanoma

Innovation is helping to prevent melanoma developing in the first place.

Research review of 2017
12 Dec 2017

Research review of 2017

Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.

Translational research funding boost
24 Nov 2017

Translational research funding boost

A prestigious Fellowship has been awarded to fund research that will change the way melanoma treatment is assessed in the future.

New research to guide clinicians to more accurately stage and manage melanoma patients
16 Nov 2017

New research to guide clinicians to more accurately stage and manage melanoma patients

New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.

Founding father recognised for outstanding cancer care
15 Nov 2017

Founding father recognised for outstanding cancer care

Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.

Melanoma researchers shine at the State's premier cancer awards ceremony
03 Nov 2017

Melanoma researchers shine at the State's premier cancer awards ceremony

Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.

Enhancing melanoma treatment response through gut bacteria
03 Nov 2017

Enhancing melanoma treatment response through gut bacteria

New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.

Melanoma March is just around the corner!
01 Nov 2017

Melanoma March is just around the corner!

2018 will be bigger than ever, and a little bit different.

Comparing melanoma risk in similar populations across different latitudes
20 Oct 2017

Comparing melanoma risk in similar populations across different latitudes

MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.

Congratulations to our Conjoint Medical Directors
19 Oct 2017

Congratulations to our Conjoint Medical Directors

Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.

What causes melanoma in 90% of young Australians?
19 Oct 2017

What causes melanoma in 90% of young Australians?

New research shows potentially deadly UV damage can appear decades earlier than you think.